What does the scale-up of long-acting HIV pre-exposure prophylaxis mean for the global hepatitis B epidemic?

Amir M MoharebMenan Gérard KouaméMarcellin NouamanArthur Y KimJoseph LarmarangeAnne M NeilanKarine Lacombe Kenneth A FreedbergAnders BoydPatrick CoffieEmily P Hyle

Published in: Journal of the International AIDS Society (2024)

Long-acting PrEP holds promise for reducing HIV incidence, but its implications for the HBV epidemic, particularly in sub-Saharan Africa, should not be overlooked.

Keyphrases

men who have sex with men
hiv positive
hiv testing
antiretroviral therapy
hiv infected
human immunodeficiency virus
hepatitis c virus
hiv aids
hepatitis b virus
risk factors
south africa
big data
machine learning